Variations of ganglioside biosynthetic pathways in the phenotype conversion from myofibroblasts to lipocytes in murine hepatic stellate cell line.
GRX cell line represents hepatic stellate cell and can be transformed from an actively proliferation myofibroblast phenotype into a quiescent fat-storing lipocyte phenotype. Both express the same gangliosides (GM3, GM2, GM1 and GD1a), which are resolved as doublets on HPTLC. Upper/lower band ratio is increased in lipocyte-like cells and the upper band is composed by ceramides with long-chain fatty acids. This study evaluated the contribution of de novo synthesis, sphingosine and Golgi recycling pathways on ganglioside biosynthesis, in both phenotypes. Cells were preincubated with 5 mM beta-chloroalanine (SPT: serine palmitoyltransferase inhibitor) or with 25 muM fumonisin B1 (ceramide synthase inhibitor) and then radiolabeled with [U-(14)C]galactose in the continued presence of inhibitors. Gangliosides were extracted, purified and analyzed by HPTLC. In myofibroblast-like cells, simple gangliosides use the de novo pathway while complex gangliosides are mainly synthesized by recycling pathways. In lipocyte-like cells, de novo pathway has a lesser contribution and this is in agreement with the lower activity of the committed enzyme of sphingolipid synthesis (SPT) detected in this phenotype. SPT mRNA has an identical expression in both phenotypes. It was also observed that gangliosides doublets from myofibroblast-like cells have the same distribution between triton soluble and insoluble fractions (upper band > lower band) while the gangliosides doublets from lipocyte-like cells show an inversion in the insoluble fraction (lower band > upper band) in comparison to soluble fraction. These results indicate that myofibroblast- and lipocyte-like cells have important differences between the glycosphingolipid biosynthetic pathways, which could contribute with the respective glycosphingolipid-enriched membrane microdomain's composition.
de Aguirres
Aline B
AB
Departamento de Bioquímica, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Rua Ramiro Barcelos 2600 - anexo, CEP 90.035-003, Porto Alegre, RS, Brazil. alinebo@terra.com.br
Mello
Paola A
PA
Andrade
Claudia M B
CM
Breier
Ana Carolina
AC
Margis
Rogério
R
Guaragna
Regina M
RM
Borojevic
Radovan
R
Guma
Fátima C R
FC
Trindade
Vera M T
VM
D017667:Adipocytes / Q000166:cytology / Q000378:metabolism* / Q000502:physiology*; D000818:Animals; D053898:Biosynthetic Pathways; D002460:Cell Line; D005347:Fibroblasts / Q000166:cytology / Q000378:metabolism*; D005732:Gangliosides / Q000378:metabolism*; D022781:Hepatocytes / Q000166:cytology* / Q000378:metabolism; D051379:Mice; D032446:Myoblasts / Q000166:cytology / Q000502:physiology*; D010641:Phenotype; D012694:Serine / Q000378:metabolism; D051102:Serine C-Palmitoyltransferase / Q000378:metabolism; D013107:Sphingolipids / Q000737:chemistry / Q000378:metabolism; D013109:Sphingomyelins / Q000737:chemistry / Q000378:metabolism
D005732:Gangliosides; D013107:Sphingolipids; D013109:Sphingomyelins; D012694:Serine; D051102:Serine C-Palmitoyltransferase